Delivery Order SPE2DB20D3303-SPE2DB25FA1YH
- Not listed
- The Defense Logistics Agency awarded a $2,977.70 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a contract ceiling value of $2,670.49 and an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $2,667.94. This delivery order represents a non-competitive, firm fixed-price procurement conducted without set-aside provisions. The order is due for completion by July 25, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units, with a ceiling value of $5,863.25 and a completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.24 to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a diabetes medication. The contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Glimepiride 4 mg tablets (100-count packages) with a ceiling value of $8,458.65. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location and serving as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,319,446 units of 2 mg glimepiride tablets. The $1,728.22 award has a completion date of January 16, 2024 and was made on January 12, 2024. This delivery order is part of a larger indefinite delivery contract held by AmerisourceBergen Drug Corp to provide pharmaceuticals and medical supplies to DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,604.97 firm fixed-price contract is for the delivery of 4,566,149,248 units of the generic medication glimepiride 2 mg tablets. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- This is a $3,916.47 delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of the drug Glimepiride 2 mg, which is used to treat diabetes. The contract is a firm fixed-price, non-set-aside contract with a completion date of May 29, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has a total potential value of $12,852.36 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will perform the work from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is part of a...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1YHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a ceiling value of $1,260.82 and an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total contract value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's global pharmaceutical support vehicle enables the delivery of a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Glimepiride, a diabetes management medication, demonstrates the company's ongoing role in supplying essential pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/29/25 |